Erector Spinae Block for Thoracic Surgery

Launched by GEORGE WASHINGTON UNIVERSITY · Aug 29, 2022

Keywords

ClinConnect Summary

This clinical trial, called the Erector Spinae Block for Thoracic Surgery, is studying a method to help reduce pain after surgery for lung cancer or other lung diseases. Researchers want to see if giving patients an injection of local anesthetic (a medication that numbs pain) in a specific area of the back can help lessen pain and decrease the need for opioid medications after surgery. This could make recovery more comfortable for patients who undergo lung surgery.

To be eligible for this study, patients should be between the ages of 18 and 90 and scheduled for a lung surgery called pulmonary resection. However, those who have certain conditions, like allergies to local anesthetics or who need emergency surgery, won't be able to participate. If you join this trial, you can expect to receive the local anesthetic injection during your surgery, and your pain levels and use of pain medications will be monitored afterward. This study aims to improve the overall experience for patients recovering from lung surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • pulmonary resection
• • 18\<age\<90
• Exclusion Criteria:
• • pleurodesis
• • decortication
• • emergent surgery
• • local anesthetic allergy
• • intraoperative complication (inadvertent hemorrhage or conversion to open surgery)
• • bilateral pulmonary resection